*From the Authors*:

We thank Dr. Pahuja and colleagues for their interest in our manuscript ([@bib1]). Length of stay (LOS) has been suggested as a meaningful outcome measure for quality of care ([@bib2]). LOS following intervention is an indirect measure of clinical improvement in pleural infection. If LOS decreases, then intervention is efficient and effective, as patients with extended LOS often consume substantial hospital resources, increase healthcare costs, and increase the risk of nosocomial infections. In pleural infection, radiological changes can often persist after clinical improvement and should not be the sole criteria for continuation of therapy or would be the only indication of treatment failure. Furthermore, treatment of either intrapleural fibrinolytic therapy or medical thoracoscopy (MT) have been shown to be effective in clinical practice, with only up to 15% requiring any further surgical intervention or referral ([@bib3], [@bib4]), making a clinical trial design with such primary outcome impractical. It is well recognized that patients with early-stage pleural infection who were initially admitted or referred for evaluation will be eventually be discharged home once they have clinical improvement and do not require chest tube or further intervention. Regarding the duration before enrollment, the inclusion criteria clearly mentions that MT could be performed within 48 hours from the time of chest tube placement, or patients would not be considered for enrollment in either arm.

Although historically large-bore chest tubes have been used for drainage of pleural infection, clinical evidence from a large prospective cohort indicated that small-bore chest tubes (≤14 F) are as effective and are better tolerated owing to less pain ([@bib5]). Based on current evidence and extensive experience, our practice is to insert small-bore chest tubes in all patients with an infected pleural space before deciding whether intrapleural fibrinolytic or MT is even needed.

Regarding MT, as mentioned in the M[ethods]{.smallcaps} section, thoracoscopy was performed under moderate sedation and local anesthesia, which was consistently done in all centers. The use of either semirigid or rigid thoracoscope, number of ports, and suction irrigator were left to the operator's preference. However, rigid MT was almost exclusively used by all operators with the goal to mechanically remove any adhesions and break down loculations. In any case, the study mentioned by the group ([@bib6]) confirmed that diagnostic yield and technical success was similar. Furthermore, pleural biopsy can be safely performed using ultrasound-guided technique or during MT if such a procedure is already planned for pleural infection.

In summary, as concluded by our study, MT can be used safely in selected patients for pleural infection and might shorten hospital stay as compared with intrapleural fibrinolytic therapy. The performance of such a procedure in pleural infection must consider the operator's expertise as well as the patient's preference and medical comorbidities during routine clinical practice.
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